Visgeneer (4197) Stock Overview
Engages in the provision of health solutions in the fields of medical device, cosmetics and skin care, Zeaxanthin, and cancer gene diagnostics in Europe and Asia. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
4197 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Join community and earn perks
Visgeneer Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$8.55 |
| 52 Week High | NT$22.50 |
| 52 Week Low | NT$7.77 |
| Beta | 0.14 |
| 1 Month Change | -5.00% |
| 3 Month Change | -6.04% |
| 1 Year Change | -14.50% |
| 3 Year Change | -28.45% |
| 5 Year Change | -34.23% |
| Change since IPO | -71.82% |
Recent News & Updates
Recent updates
Shareholder Returns
| 4197 | TW Medical Equipment | TW Market | |
|---|---|---|---|
| 7D | -0.2% | 0.9% | 3.6% |
| 1Y | -14.5% | -28.8% | 86.2% |
Return vs Industry: 4197 exceeded the TW Medical Equipment industry which returned -28.8% over the past year.
Return vs Market: 4197 underperformed the TW Market which returned 86.2% over the past year.
Price Volatility
| 4197 volatility | |
|---|---|
| 4197 Average Weekly Movement | 10.1% |
| Medical Equipment Industry Average Movement | 4.5% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in TW Market | 12.0% |
| 10% least volatile stocks in TW Market | 2.7% |
Stable Share Price: 4197's share price has been volatile over the past 3 months compared to the TW market.
Volatility Over Time: 4197's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of TW stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | n/a | Kengshuo Dai | www.visgeneer.com.tw |
Visgeneer Inc. engages in the provision of health solutions in the fields of medical device, cosmetics and skin care, Zeaxanthin, and cancer gene diagnostics in Europe and Asia. The company offers blood glucose and ketone, uric acid, and cholesterol monitoring systems. It also provides functional masks, such as wood pulp mask, invisible mask, black mask, pure cloth mask, and bio cellulose mask; face cream, night cream, day cream, wrinkle cream, repairing cream, whitening cream, exfoliating cream, toner, and lotions; functional essences; body lotion and spa clay mask; physical blocker, chemical blocker, and comprehensive sun protection; face wash, wash cream, cleaning cleansing mousse, cleaning cleansing gel, shampoo, and body wash; hand cream, knee cream, foot mask, hand mask, and glucosamine cream; anti-acne cream, female private cleaning lotion, skin care, skin capsules, and hair capsules; and customized skin care products.
Visgeneer Inc. Fundamentals Summary
| 4197 fundamental statistics | |
|---|---|
| Market cap | NT$258.05m |
| Earnings (TTM) | -NT$3.75m |
| Revenue (TTM) | NT$170.72m |
Is 4197 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4197 income statement (TTM) | |
|---|---|
| Revenue | NT$170.72m |
| Cost of Revenue | NT$117.58m |
| Gross Profit | NT$53.14m |
| Other Expenses | NT$56.89m |
| Earnings | -NT$3.75m |
Last Reported Earnings
Jun 30, 2026
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.12 |
| Gross Margin | 31.13% |
| Net Profit Margin | -2.20% |
| Debt/Equity Ratio | 52.0% |
How did 4197 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/08/17 17:55 |
| End of Day Share Price | 2026/08/17 00:00 |
| Earnings | 2026/06/30 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Visgeneer Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.